Skip to main content
Clinical Trials/IRCT201706199014N170
IRCT201706199014N170
Recruiting
Phase 2

Comparison of treatment effect of fixed and non-fixed interval prescription of Actinomycin-D on ß-HCG level among patients with low-grade gestational trophoblastic neoplasia: a double blind randomized clinical trial

Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences0 sites76 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Trophoblastic neoplasia.
Sponsor
Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences
Enrollment
76
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Vice-chancellor for Research and Technology, Hamadan University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • Age of 16 to 50 years; low\-grade gestational trophoblastic neoplasia; no response to methotrexate.
  • Exclusion criteria: Pregnancy or breastfeeding; history of herpes or chicken Pox infection; liver or kidney or bone marrow disorder.

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Not specified

Similar Trials